Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

396
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
396
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

264
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

293
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
293
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson's disease.

The Journal of pharmacy and pharmacology·2026
Same author

Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment.

Drug delivery and translational research·2026
Same author

CFTR mRNA-Based Gene Therapy for Cystic Fibrosis: A Mutation-Agnostic Strategy to Restore Ion Transport Function.

Current gene therapy·2026
Same author

Mechanistic Insights and Therapeutic Advances in Natural Bioactive Compounds as Multi-target Agents in Rheumatoid Arthritis.

Current rheumatology reviews·2026
Same author

Stimuli-Responsive Carbon Nanotubes for On-Demand Cancer Therapy: A Review.

AAPS PharmSciTech·2026
Same author

Plant-Powered Nanotechnology: A Review of Green Synthesis Approaches for ZnO and Silver Nanoparticles with Medicinal Flora.

Current topics in medicinal chemistry·2026

Related Experiment Video

Updated: Jan 8, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K

Heart Failure Management in the Modern Era: A Comprehensive Review on Medical and Device-based Interventions.

Aman Shrivastava1, Niharika Gokhale2, Pritesh Paliwal3

  • 1Department of Pharmacology, College of Pharmacy, Institute of Professional Studies, Gwalior, Madhya Pradesh, India.

Current Cardiology Reviews
|December 16, 2025
PubMed
Summary

Heart failure management integrates advanced medical therapies and implantable devices. These treatments significantly reduce mortality and improve quality of life for patients with heart conditions.

Keywords:
Heart failurecardiovascular disordersetiology.implantable devicesmedical therapysynergetic potential

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Related Experiment Videos

Last Updated: Jan 8, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Area of Science:

  • Cardiology
  • Medical Device Technology

Background:

  • Heart failure is a major global health issue requiring improved management strategies.
  • Current approaches focus on optimizing patient outcomes through integrated therapies.

Purpose of the Study:

  • To review the current landscape of heart failure management.
  • To explore the integration of pharmacologic treatments and implantable device interventions.

Main Methods:

  • Comprehensive review of current guidelines and evidence.
  • Synthesis of recent advancements in medical and device-based therapies for heart failure.

Main Results:

  • Pharmacologic agents like ACE inhibitors and SGLT2 blockers are primary treatments, reducing mortality and morbidity.
  • Implantable devices, including cardiac resynchronization therapy and cardioverter-defibrillators, offer significant benefits for specific patient groups.
  • Left bundle branch area pacing presents an alternative to traditional CRT, and remote monitoring enhances management precision.

Conclusions:

  • Integrating guideline-directed medical therapy with advanced device interventions is crucial for effective heart failure management.
  • Novel device innovations and remote monitoring are key to enhancing precision and efficacy.
  • Further research should focus on the synergistic potential and practical implementation of these combined strategies.